A Study to Evaluate Electrocardiogram and Heart Disease in Women


About this study

The purpose of this study is to determine the feasibility and effectiveness of electrocardiogram (ECG) to detect a form of heart failure among women of childbearing age (ages 18-49 years). 

Heart disease is the leading cause of mortality during peripartum and postpartum period. Screening for heart disease during pregnancy, however, is a significant unmet need. If proven to be effective, this test can be used as a screening tool for early detection of heart failure among women who are contemplating pregnancy, currently pregnant or recently delivered a child. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult female aged 18 – 49 years.
  • Pregnant women can participate (minimal risk study, with no risk from obtaining an ECG)
  • Willing and able to provide informed consent

Exclusion Criteria:

  • Unwilling or unable to provide informed consent.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Anja Kinaszczuk, D.O.

Open for enrollment

Contact information:

Erika Douglass M.P.H.

(904) 953-6595


More information


Publications are currently not available

Mayo Clinic Footer